Novel Peptide Vaccine Reduces Mortality in Women With HER2-Overexpression Breast Cancer
A novel peptide vaccine was able to reduce the mortality rate in women with HER2/neu overexpressing breast cancer by about half, researchers report here at the American Association for Cancer Research (AACR) 2008 Annual Meeting.
“The numbers in this study are small but the concept is good,” commented William N. Hait, MD, PhD, president of the AACR and senior vice president of Worldwide Hematology and Oncology Research and Development at Johnson & Johnson. “It’s a good first step and we are cautiously optimistic.”
(more…)
